Literature DB >> 17425916

Efficacy of lifestyle behavior change programs in diabetes.

Elizabeth M Venditti1.   

Abstract

Evidence that a comprehensive lifestyle behavior change program targeting eating and physical activity, and ultimately weight loss, can alter the course of diabetes progression is growing. This report summarizes data from major clinical trials primarily, describes key features of behavior change programs, and comments on existing challenges regarding the adequacy, sustainability, and feasibility of behavior change programs for weight loss and diabetes prevention.

Entities:  

Mesh:

Year:  2007        PMID: 17425916     DOI: 10.1007/s11892-007-0021-7

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   5.430


  27 in total

Review 1.  Weight management through lifestyle modification for the prevention and management of type 2 diabetes: rationale and strategies: a statement of the American Diabetes Association, the North American Association for the Study of Obesity, and the American Society for Clinical Nutrition.

Authors:  Samuel Klein; Nancy F Sheard; Xavier Pi-Sunyer; Anne Daly; Judith Wylie-Rosett; Karmeen Kulkarni; Nathaniel G Clark
Journal:  Diabetes Care       Date:  2004-08       Impact factor: 19.112

2.  Using RE-AIM metrics to evaluate diabetes self-management support interventions.

Authors:  Russell E Glasgow; Candace C Nelson; Lisa A Strycker; Diane K King
Journal:  Am J Prev Med       Date:  2006-01       Impact factor: 5.043

3.  Lifestyle intervention in overweight individuals with a family history of diabetes.

Authors:  R R Wing; E Venditti; J M Jakicic; B A Polley; W Lang
Journal:  Diabetes Care       Date:  1998-03       Impact factor: 19.112

4.  Effect of weight loss with lifestyle intervention on risk of diabetes.

Authors:  Richard F Hamman; Rena R Wing; Sharon L Edelstein; John M Lachin; George A Bray; Linda Delahanty; Mary Hoskin; Andrea M Kriska; Elizabeth J Mayer-Davis; Xavier Pi-Sunyer; Judith Regensteiner; Beth Venditti; Judith Wylie-Rosett
Journal:  Diabetes Care       Date:  2006-09       Impact factor: 19.112

5.  Prevention of Type II diabetes in subjects with impaired glucose tolerance: the Diabetes Prevention Study (DPS) in Finland. Study design and 1-year interim report on the feasibility of the lifestyle intervention programme.

Authors:  J Eriksson; J Lindström; T Valle; S Aunola; H Hämäläinen; P Ilanne-Parikka; S Keinänen-Kiukaanniemi; M Laakso; M Lauhkonen; P Lehto; A Lehtonen; A Louheranta; M Mannelin; V Martikkala; M Rastas; J Sundvall; A Turpeinen; T Viljanen; M Uusitupa; J Tuomilehto
Journal:  Diabetologia       Date:  1999-07       Impact factor: 10.122

6.  Effect of sibutramine on weight maintenance after weight loss: a randomised trial. STORM Study Group. Sibutramine Trial of Obesity Reduction and Maintenance.

Authors:  W P James; A Astrup; N Finer; J Hilsted; P Kopelman; S Rössner; W H Saris; L F Van Gaal
Journal:  Lancet       Date:  2000 Dec 23-30       Impact factor: 79.321

Review 7.  Efficacy of lifestyle modification for long-term weight control.

Authors:  Thomas A Wadden; Meghan L Butryn; Kirstin J Byrne
Journal:  Obes Res       Date:  2004-12

8.  Weight change and diabetes incidence: findings from a national cohort of US adults.

Authors:  E S Ford; D F Williamson; S Liu
Journal:  Am J Epidemiol       Date:  1997-08-01       Impact factor: 4.897

Review 9.  Lifestyle strategies for weight control: experience from the Finnish Diabetes Prevention Study.

Authors:  Jaana Lindström; Markku Peltonen; Jaakko Tuomilehto
Journal:  Proc Nutr Soc       Date:  2005-02       Impact factor: 6.297

10.  Benefits of lifestyle modification in the pharmacologic treatment of obesity: a randomized trial.

Authors:  T A Wadden; R I Berkowitz; D B Sarwer; R Prus-Wisniewski; C Steinberg
Journal:  Arch Intern Med       Date:  2001-01-22
View more
  1 in total

Review 1.  Necessary components for lifestyle modification interventions to reduce diabetes risk.

Authors:  Elizabeth M Venditti; M Kaye Kramer
Journal:  Curr Diab Rep       Date:  2012-04       Impact factor: 4.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.